From April 1, 2022 to June 30, 2022, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 5,300,000 shares, representing 5.43% for $1,127.91 million under the buyback announced on February 7, 2019.
Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
201.5 USD | +1.02% | -0.90% | -11.36% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.36% | 16.78B | |
-11.66% | 87.46B | |
+12.72% | 78.56B | |
+10.85% | 29.37B | |
-4.17% | 16.01B | |
-6.85% | 13.98B | |
+0.92% | 12.31B | |
-30.35% | 12.07B | |
+22.01% | 11.06B | |
0.00% | 11.06B |
- Stock Market
- Equities
- LH Stock
- News Laboratory Corporation of America Holdings
- Tranche Update on Laboratory Corporation of America Holdings (NYSE: LH)'s Equity Buyback Plan announced on February 7, 2019.